Thorne HealthTech’s Onedraw Device Used In Department Of Defense’s Cancer Moonshot 2.0 Project, Prometheus, As Part Of President Biden Initiative
Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, announced today that its
Thorne HealthTech Earnings Preview
Thorne HealthTech (NASDAQ:THRN) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement.
Analysts estimate that Thorne HealthTech will report an earnings per share (EPS) of $0.14.
Thorne Healthtech, Team Liquid Announce Partnership Bringing Health And Wellness Solutions To eSports Community
Thorne HealthTech ("Thorne") (NASDAQ:THRN), the leader in developing innovative solutions for a personalized approach to health and wellness and Team Liquid, a leading worldwide professional esports
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Thorne Relaunches Its Gut Health Test
Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and well-being, today relaunched its Gut
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell
• Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Thorne HealthTech Appoints Bryan Conley As Finance Head
Thorne HealthTech Inc (NASDAQ:THRN) Board has appointed Bryan K. Conley as Chief Financial Officer (CFO), effective April 1, 2022. He succeeds Scott…
Thorne HealthTech Q4 Sales $49.90M Beat $49.08M Estimate
Thorne HealthTech (NASDAQ:THRN) reported quarterly sales of $49.90 million which beat the analyst consensus estimate of $49.08 million by 1.67 percent.